Efficacy and Safety of REC-4881 in Participants With Familial Adenomatous Polyposis (FAP)

Efficacy and Safety of REC-4881 in Participants With Familial Adenomatous Polyposis (FAP)
Condition:   Familial Adenomatous Polyposis
Interventions:   Drug: REC-4881;   Drug: Placebo
Sponsor:   Recursion Pharmaceuticals Inc.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 30, 2022Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Comments